To make it easier for people with diabetes to track their insulin doses, Novo Nordisk has inked a deal with devicemaker Biocorp to smarten up its line of mass-produced, disposable insulin pens.

Princeton, NJ (September 27, 2004) – In type 2 diabetes patients, use of NovoLog® Mix 70/30 FlexPen® (70% insulin aspart protamine suspension and 30% insulin aspart injection, [rDNA origin]), a ...

Eli Lilly & Co. has signed a deal to link Welldoc’s digital health platform with its upcoming connected insulin devices and therapies. The two will collaborate on a new version of Welldoc’s ...

Please provide your email address to receive an email when new articles are posted on . The FDA granted 501(k) clearance to a smart cap sensor for disposable insulin pens, according to an industry ...

MISSISSAUGA, ON, Oct. 18, 2013 /CNW/ - Novo Nordisk today announced that Health Canada has approved Levemir® FlexTouch®, a disposable prefilled insulin pen containing Levemir® (insulin detemir).

Study design. This prospective, randomized, controlled, parallel-group study compared the use of pen devices with conventional vials and syringes for the administration of insulin in hospitalized ...

DUBLIN--(BUSINESS WIRE)--The "Diabetes Insulin Delivery Pens Market Research Report 2018" report has been added to ResearchAndMarkets.com's offering. Diabetes Insulin Delivery Pen market will surpass ...

Sanofi and Roche have joined forces in France, teaming up to drive adoption of a connected add-on for disposable insulin pens. The partners will jointly develop a scientific program for physicians and ...

DUBLIN--(BUSINESS WIRE)--The "Global Insulin Pen Market 2023-2028" report has been added to ResearchAndMarkets.com's offering. The global insulin pen market is projected to achieve a significant ...

The Bigfoot Unity System uses iCGM data from Abbott’s FreeStyle Libre 2 system and consists of smart pen caps for rapid- and long-acting insulin, as well as a mobile app. The Food and Drug ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. Nine percent of Americans, about 30 million people, have ...

NEW YORK, June 21, 2019 /PRNewswire/ -- The global insulin pens market is expected to reach US$ 8,286.6 Mn in 2027 from US$ 3,957.0 in 2018. The market is estimated to grow with a CAGR of 8.8% from ...